BackAdvanced BioMedical Technologies Overview

Advanced BioMedical Technologies Operating Income

Advanced BioMedical Technologies's operating income is $-150K.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-106819.00
↓ 4.43% YoY

As of Jul 31, 2022

Annual Operating Income (TTM)

$-149362.00
↓ 64.75% YoY

Trailing 12 months ending Jul 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Advanced BioMedical Technologies (ABMT) FAQ

As of the most recent data (July 2022), ABMT shows a operating income of $-150K. That compares with $-420K in the prior-year period — up 64.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABMT's operating income is now $-150K (was $-420K) — a 64.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Advanced BioMedical Technologies is outperforming or lagging.

Tracking ABMT's operating income over time shows whether Advanced BioMedical Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $-150K That compares with $-420K in the prior-year period — up 64.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Advanced BioMedical Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-150K) with ownership activity and broader fundamentals.